 |
 |
NINDS Seeks Newly Diagnosed Parkinson's Disease Patients Investigators at the National Institute of Neurological Disorders and Stroke (NINDS) are seeking newly diagnosed Parkinson's disease patients for a neuroprotective trial involving a new free radical scavenger drug aimed at stopping the progression of the disease. The study will be a two year outpatient trial requiring quarterly visits to the NIH in Bethesda, MD, and more frequent safety visits to a local physician. Eligible patients should be age 18-80, otherwise healthy, ambulatory, and on no antiparkinsonian mediacation (or treated with Sinemet or dopamine agonists for less than six months and able to discontinue these medicines). Study-related expenses will be paid by the NINDS. Interested individuals should should have their physicians send or FAX a letter of referral and case summary to: Dr. Thomas Chase, Experimental Therapeutics Branch, NINDS, NIH, Building 10, Room 5C-106, 10 CENTER DR MSC 1406, BETHESDA MD 20892-1406. Fax number: 301-496-6609. For further information, please E-mail Marge Gillespie at [log in to unmask] After May 8th, 1995, please call: 1-800-362-3479